Vertaile menetelmiä
Tarkastele valitsemiasi menetelmiä rinnakkain; eroavat rivit korostetaan.
| Parkinsonin taudin ei-motoristen oireiden asteikko (NMSS)× | Migreenin haitta-asteen arviointiasteikko (MIDAS)× | |
|---|---|---|
| Tieteenala | Neurologia | Neurologia |
| Menetelmäperhe | Process / pipeline | Process / pipeline |
| Syntyvuosi≠ | 2007 | 1999 |
| Kehittäjä≠ | K. Ray Chaudhuri, National Hospital for Neurology and Neurosurgery, London | William F. Stewart, Johns Hopkins University |
| Tyyppi≠ | Self-report questionnaire and clinician interview | Self-report questionnaire |
| Alkuperäislähde≠ | Chaudhuri, K. R., Martinez-Martin, P., Brown, R. G., Sethi, K., Stocchi, F., Odin, P., Ondo, W., Whone, A., Rye, D., Bhattacharya, K., Naidu, Y., Schapira, A. H., Brozova, H., Nutt, J., Macphee, G., Carroll, C., Hilten, J. V., Verschuuren, J., & Bonuccelli, U. (2007). The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Movement Disorders, 22(13), 1901-1911. DOI ↗ | Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (1999). Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire. Neurology, 53(Suppl 3), S23-S28. DOI ↗ |
| Rinnakkaisnimet≠ | Parkinson's Non-Motor Scale, NMSQ, NMS Scale | MIDAS Scale, Migraine Disability Assessment |
| Liittyvät≠ | 4 | 2 |
| Tiivistelmä≠ | The NMSS is a comprehensive 30-item scale designed to assess the prevalence and impact of non-motor symptoms (NMS) in Parkinson's disease. Developed by Chaudhuri and colleagues in 2007, it addresses the reality that non-motor features—sleep disorders, mood disturbances, autonomic dysfunction, cognitive impairment, and pain—often cause greater disability and suffering than motor symptoms in many PD patients. The scale is essential for comprehensive PD assessment and is increasingly recognized as a critical outcome measure reflecting true patient burden. | The MIDAS is a brief, five-item self-report questionnaire that quantifies migraine-related disability by measuring days lost from work, school, household activities, and family/social activities over a 3-month period. Introduced by Stewart and colleagues in 1999, it is the most widely used measure of migraine burden in clinical practice and research. MIDAS directly translates migraine frequency and severity into functional impact (lost productivity, lost days), enabling healthcare providers and patients to understand the true disability burden of migraines. |
| ScholarGateAineisto ↗ |
|
|